4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-222185
10% owner sold 133,618 shares at $40.24 ($5,377,323)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. 10% owner | 2026-05-11 | Sale 10b5-1 | −133,618 | $40.24 | $5,377,323 | 6,299,097 | D: show line 1 in the form |
| Open-market sales · 133,618 sh · avg $40.24 · $5,377,323 | |||||||
Loading xslF345X06/ownership.xml…